Improvement in docetaxel-induced nail changes associated with cyclooxygenase-2 inhibitor treatment.
Nakamura
S
S
Kajita
S
S
Takagi
A
A
Hashimoto
Y
Y
Ishida-Yamamoto
A
A
Takahashi
H
H
Iizuka
H
H
D000970:Antineoplastic Agents / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000188:drug therapy; D052246:Cyclooxygenase 2 Inhibitors / Q000627:therapeutic use*; D000077143:Docetaxel; D005260:Female; D006801:Humans; D000077239:Meloxicam; D008875:Middle Aged; D009260:Nail Diseases / Q000139:chemically induced / Q000188:drug therapy; D043823:Taxoids / Q000009:adverse effects*; D013843:Thiazines / Q000627:therapeutic use*; D013844:Thiazoles / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D052246:Cyclooxygenase 2 Inhibitors; D043823:Taxoids; D013843:Thiazines; D013844:Thiazoles; D000077143:Docetaxel; D000077239:Meloxicam